Total Payments
$1.7M
2024 Payments
$212,404
Companies
29
Transactions
223
Medicare Patients
10,799
Medicare Billing
$7.6M
Payment Breakdown by Category
Royalty/License$1.1M (60.7%)
Consulting$581,577 (33.5%)
Other$47,950 (2.8%)
Travel$40,177 (2.3%)
Food & Beverage$10,577 (0.6%)
Research$687.50 (0.0%)
Gifts$188.01 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $1.1M | 33 | 60.7% |
| Consulting Fee | $581,577 | 41 | 33.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $47,950 | 8 | 2.8% |
| Travel and Lodging | $40,177 | 31 | 2.3% |
| Food and Beverage | $10,577 | 106 | 0.6% |
| Unspecified | $687.50 | 1 | 0.0% |
| Gift | $188.01 | 3 | 0.0% |
Payments by Type
General
$1.7M
222 transactions
Research
$687.50
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TOPCON MEDICAL SYSTEMS, INC. | $1.1M | 65 | $0 (2023) |
| Heidelberg Engineering, Inc. | $201,048 | 8 | $0 (2023) |
| Topcon Healthcare, Inc. | $197,486 | 6 | $0 (2024) |
| TOPCON CORPORATION | $106,034 | 20 | $0 (2019) |
| F. Hoffmann-La Roche AG | $59,822 | 6 | $0 (2023) |
| Regeneron Pharmaceuticals, Inc. | $25,337 | 10 | $0 (2024) |
| Genentech, Inc. | $23,162 | 18 | $0 (2022) |
| Dutch Ophthalmic Research Center (International) B.V. | $18,897 | 4 | $0 (2020) |
| Boehringer Ingelheim Pharma GmbH & Co.KG | $11,676 | 5 | $0 (2017) |
| Janssen Global Services, LLC | $6,568 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $212,404 | 19 | Topcon Healthcare, Inc. ($197,486) |
| 2023 | $291,481 | 39 | TOPCON MEDICAL SYSTEMS, INC. ($216,278) |
| 2022 | $212,907 | 18 | TOPCON MEDICAL SYSTEMS, INC. ($167,900) |
| 2021 | $344,629 | 14 | TOPCON MEDICAL SYSTEMS, INC. ($193,204) |
| 2020 | $275,181 | 24 | TOPCON MEDICAL SYSTEMS, INC. ($256,656) |
| 2019 | $168,434 | 53 | TOPCON MEDICAL SYSTEMS, INC. ($119,329) |
| 2018 | $150,538 | 32 | TOPCON MEDICAL SYSTEMS, INC. ($76,065) |
| 2017 | $79,858 | 24 | TOPCON MEDICAL SYSTEMS, INC. ($44,152) |
All Payment Transactions
223 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 10/25/2024 | Topcon Healthcare, Inc. | TRC-NW400 (Device) | Royalty or License | Cash or cash equivalent | $30,758.00 | General |
| Category: CAMERA, OPHTHALMIC, AC-POWERED | ||||||
| 10/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/20/2024 | Topcon Healthcare, Inc. | — | Food and Beverage | Cash or cash equivalent | $203.19 | General |
| 08/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Ophthalmology | ||||||
| 08/14/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.10 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/05/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Ophthalmology | ||||||
| 07/26/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Consulting Fee | Cash or cash equivalent | $5,400.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/26/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Consulting Fee | Cash or cash equivalent | $5,400.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/26/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/19/2024 | Topcon Healthcare, Inc. | TRC-NW400 (Device) | Royalty or License | Cash or cash equivalent | $34,875.00 | General |
| Category: CAMERA, OPHTHALMIC, AC-POWERED | ||||||
| 06/03/2024 | Topcon Healthcare, Inc. | — | Consulting Fee | Cash or cash equivalent | $66,025.00 | General |
| 05/23/2024 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $370.00 | General |
| 05/06/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Consulting Fee | Cash or cash equivalent | $1,387.50 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 05/06/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 04/23/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Ophthalmology | ||||||
| 04/19/2024 | Topcon Healthcare, Inc. | TRC-NW400 (Device) | Royalty or License | Cash or cash equivalent | $31,875.00 | General |
| Category: CAMERA, OPHTHALMIC, AC-POWERED | ||||||
| 04/19/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $34.03 | General |
| Category: Ophthalmology | ||||||
| 01/26/2024 | Topcon Healthcare, Inc. | TRC-NW400 (Device) | Royalty or License | Cash or cash equivalent | $33,750.00 | General |
| Category: CAMERA, OPHTHALMIC, AC-POWERED | ||||||
| 12/15/2023 | TOPCON MEDICAL SYSTEMS, INC. | — | Consulting Fee | Cash or cash equivalent | $30,000.00 | General |
| 12/15/2023 | TOPCON MEDICAL SYSTEMS, INC. | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 11/22/2023 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $2,220.00 | General |
| 11/22/2023 | Janssen Global Services, LLC | — | Travel and Lodging | Cash or cash equivalent | $379.65 | General |
| 11/22/2023 | Janssen Global Services, LLC | — | Travel and Lodging | Cash or cash equivalent | $13.20 | General |
| 11/21/2023 | Alcon Research LLC | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| DEEP LEARNING TO PREDICT GEOGRAPHIC ATROPHY AREA AND GROWTH RATE FROM MULTI-MODAL IMAGING | F. Hoffmann-La Roche AG | $687.50 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,864 | 37,194 | $3.0M | $1.9M |
| 2022 | 18 | 2,792 | 13,236 | $2.9M | $2.1M |
| 2021 | 14 | 2,641 | 8,323 | $2.5M | $1.9M |
| 2020 | 15 | 2,502 | 7,903 | $2.4M | $1.8M |
Total Patients
10,799
Total Services
66,656
Medicare Billing
$7.6M
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 94 | 30,420 | $1.2M | $885,719 | 77.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 103 | 870 | $799,371 | $601,992 | 75.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 208 | 908 | $472,489 | $101,403 | 21.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 336 | 1,123 | $148,424 | $87,576 | 59.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 25 | 447 | $120,890 | $81,515 | 67.4% |
| 92134 | Imaging of retina | Office | 2023 | 685 | 1,682 | $107,517 | $58,937 | 54.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 386 | 415 | $70,492 | $43,780 | 62.1% |
| 92250 | Photography of the retina | Office | 2023 | 556 | 685 | $43,881 | $22,540 | 51.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 147 | 147 | $69,876 | $18,065 | 25.9% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 223 | 394 | $19,196 | $5,396 | 28.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 17 | 17 | $3,298 | $2,202 | 66.8% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 34 | 36 | $3,857 | $1,644 | 42.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 27 | 27 | $2,821 | $1,581 | 56.0% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 23 | 23 | $965.46 | $473.13 | 49.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 173 | 1,722 | $1.6M | $1.2M | 75.5% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 44 | 1,167 | $394,994 | $261,075 | 66.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 38 | 4,560 | $186,504 | $136,077 | 73.0% |
| 67028 | Injection of drug into eye | Office | 2022 | 239 | 1,064 | $178,637 | $115,989 | 64.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 357 | 1,230 | $144,864 | $98,450 | 68.0% |
| J3590 | Unclassified biologics | Office | 2022 | 13 | 42 | $90,641 | $64,520 | 71.2% |
| 92134 | Imaging of retina | Office | 2022 | 604 | 1,719 | $91,837 | $61,962 | 67.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 317 | 354 | $58,982 | $36,349 | 61.6% |
| 92250 | Photography of the retina | Office | 2022 | 423 | 549 | $39,471 | $18,416 | 46.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 120 | 120 | $27,261 | $14,661 | 53.8% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 226 | 388 | $35,007 | $5,548 | 15.8% |
About Dr. Richard Spaide, MD
Dr. Richard Spaide, MD is a Specialist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730281957.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Spaide, MD has received a total of $1.7M in payments from pharmaceutical and medical device companies, with $212,404 received in 2024. These payments were reported across 223 transactions from 29 companies. The most common payment nature is "Royalty or License" ($1.1M).
As a Medicare-enrolled provider, Spaide has provided services to 10,799 Medicare beneficiaries, totaling 66,656 services with total Medicare billing of $7.6M. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Ophthalmology
- Location New York, NY
- Active Since 09/01/2006
- Last Updated 03/20/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1730281957
Products in Payments
- RETINAL CAMERAS (Device) $363,177
- Spectralis (Device) $201,048
- NW500 (Device) $150,007
- TRC-NW400 (Device) $131,258
- OCT-MAESTRO (Device) $119,646
- TRC-50DX (Device) $111,758
- OCT-TRITON (Device) $86,937
- SPAIDE (FAF) FILTERS (Device) $63,946
- TRC-NW-400 (Device) $61,881
- TRC-NW-403 (Device) $34,510
- OCT TRITON (Device) $33,972
- TRC-NW-402 (Device) $29,625
- EYLEA (Biological) $25,330
- TRC-NW-401 (Device) $24,384
- DRI-OCT-TRITON (Device) $17,500
- VisionBlue (Drug) $16,082
- RETINAL FILTERS (Device) $16,005
- Lucentis (Biological) $7,812
- EVA Ophthalmic Surgical System (Device) $2,815
- EYP-1901 (Drug) $1,410
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in New York
Dr. Eric Rose, M.d, M.D
Specialist — Payments: $4.9M
Specialist $4.9M
Dr. Baron Lonner, M.d, M.D
Specialist — Payments: $2.9M
Specialist $2.9M
Dr. Marla Dubinsky, M.d, M.D
Specialist — Payments: $1.6M
Specialist $1.6M
Mrs. Naomi Nakao, M.d, M.D
Specialist — Payments: $1.1M
Specialist $1.1M
Dr. Janice Dutcher, M.d, M.D
Specialist — Payments: $994,054
Specialist $994,054
Grace Hyun, Md, MD
Specialist — Payments: $851,352
Specialist $851,352